Keyword: patent expiration

Markets & Companies

Bridging the Innovation Gap

02.09.2016 - During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...

News

Pfizer to Split Generic, Branded Drugs Units

30.07.2013 - Pfizer, in what could be the prelude to spinning off its generics drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected...

News

Sanofi Fined in Plavix Generics Dispute

14.05.2013 - The French Competition Authority fined drugmaker Sanofi €40.6 million ($52.7 million) on Tuesday for "disparaging" generic competition to its Plavix blood thinner. The decision on...

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

Biotech M&A at 4-Year High as Pharma Faces Expiring Patents

03.08.2012 - Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...

News

Small Generic Drug Firms Need Niches to Survive Looming Price War

21.07.2012 - Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...